131 related articles for article (PubMed ID: 38104526)
21. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
Neeyalavira V; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
[TBL] [Abstract][Full Text] [Related]
23. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
[TBL] [Abstract][Full Text] [Related]
24. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
Weinberg LE; Lurain JR; Singh DK; Schink JC
Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
[TBL] [Abstract][Full Text] [Related]
25. Giving Birth After Fertility Sparing Treatment of Embrional Carcinoma Figo III C: Case Report and Literature Review.
Cerovac A; Ljuca D; Nevacinovic E; Tulumovic A; Iljazovic E
Med Arch; 2018 Nov; 72(5):371-373. PubMed ID: 30524172
[TBL] [Abstract][Full Text] [Related]
26. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
27. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
[TBL] [Abstract][Full Text] [Related]
28. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
[TBL] [Abstract][Full Text] [Related]
29. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
[TBL] [Abstract][Full Text] [Related]
30. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870
[TBL] [Abstract][Full Text] [Related]
31. Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.
Chen CA; Lin H; Weng CS; Wen KC; Lu CH; Chou HH; Huang YF; Kang CY; Ho CM; Yu MH; Chou CY
Eur J Cancer; 2014 Dec; 50(18):3161-7. PubMed ID: 25459394
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
[TBL] [Abstract][Full Text] [Related]
33. Reproductive outcomes following fertility-sparing surgery for malignant ovarian germ cell tumors: A systematic review of the literature.
Morrison A; Nasioudis D
Gynecol Oncol; 2020 Aug; 158(2):476-483. PubMed ID: 32513565
[TBL] [Abstract][Full Text] [Related]
34. Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".
Solheim O; Tropé CG; Rokkones E; Kærn J; Paulsen T; Salvesen HB; Hagen B; Vereide AB; Fosså SD
Gynecol Oncol; 2015 Feb; 136(2):224-9. PubMed ID: 25511159
[TBL] [Abstract][Full Text] [Related]
35. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
37. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience.
Ali A; Sayed H; Salem M; Hamdy M; Farok A
J Pediatr Surg; 2018 Apr; 53(4):837-840. PubMed ID: 28919321
[TBL] [Abstract][Full Text] [Related]
39. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
[TBL] [Abstract][Full Text] [Related]
40. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]